139 related articles for article (PubMed ID: 22191613)
1. Magnetic resonance contrast media sensing in vivo molecular imaging agents: an overview.
Amanlou M; Siadat SD; Norouzian D; Ebrahimi SE; Aghasadeghi MR; Ghorbani M; Alavidjeh MS; Inanlou DN; Arabzadeh AJ; Ardestani MS
Curr Radiopharm; 2011 Jan; 4(1):31-43. PubMed ID: 22191613
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
3. Molecular Magnetic Resonance Imaging (mMRI).
Gauberti M; Fournier AP; Vivien D; Martinez de Lizarrondo S
Methods Mol Biol; 2018; 1718():315-327. PubMed ID: 29341017
[TBL] [Abstract][Full Text] [Related]
4. Targeted contrast agents in MR imaging.
Gupta H; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
[TBL] [Abstract][Full Text] [Related]
5. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
Runge VM
Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
[TBL] [Abstract][Full Text] [Related]
6. Molecular and magnetic resonance imaging: The value of immunoliposomes.
Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
[TBL] [Abstract][Full Text] [Related]
7. Main applications of hybrid PET-MRI contrast agents: a review.
Kiani A; Esquevin A; Lepareur N; Bourguet P; Le Jeune F; Gauvrit J
Contrast Media Mol Imaging; 2016; 11(2):92-8. PubMed ID: 26632007
[TBL] [Abstract][Full Text] [Related]
8. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C
Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765
[TBL] [Abstract][Full Text] [Related]
11. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
12. Nanoprobes for hybrid SPECT/MR molecular imaging.
Misri R; Saatchi K; Häfeli UO
Nanomedicine (Lond); 2012 May; 7(5):719-33. PubMed ID: 22630153
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging with targeted contrast agents.
Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
[TBL] [Abstract][Full Text] [Related]
14. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN
Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging and spectroscopy methods for molecular imaging.
Vande Velde G; Baekelandt V; Dresselaers T; Himmelreich U
Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):565-85. PubMed ID: 20016450
[TBL] [Abstract][Full Text] [Related]
16. Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging?
Ploussi AG; Gazouli M; Stathis G; Kelekis NL; Efstathopoulos EP
Cardiol Rev; 2015; 23(5):229-35. PubMed ID: 25688663
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
[TBL] [Abstract][Full Text] [Related]
18. Molecular magnetic resonance imaging with targeted contrast agents.
Artemov D
J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid.
Fujimoto Y; Okuhata Y; Tyngi S; Namba Y; Oku N
Biol Pharm Bull; 2000 Jan; 23(1):97-100. PubMed ID: 10706419
[TBL] [Abstract][Full Text] [Related]
20. An introduction to functional and molecular imaging with MRI.
Gallagher FA
Clin Radiol; 2010 Jul; 65(7):557-66. PubMed ID: 20541655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
